Abstract
Drug-induced long QT syndrome (diLQTS) can lead to seemingly healthy patients experiencing cardiac arrest, specifically Torsades de Pointes (TdP). A goal of this study is to identify genetic risk markers for diLQTS and TdP for prevention of genetic-related heart disease. We use data that were made available for general research use by National Center for Biotechnology Information, focused on subjects with a history of diLQTS or TdP after taking medication. Statistical learning algorithms were used to build a predictive model. The proposed approach can provide the likelihood of benefit for the treatment based on a set of genetic markers.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Communications in Statistics: Case Studies, Data Analysis and Applications
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
